Luger, S. M., Ringdén, O., Zhang, M., Pérez, W. S., Bishop, M. R., Bornhauser, M., . . . Pulsipher, M. A. (2011). SIMILAR OUTCOMES USING MYELOABLATIVE VERSUS REDUCED INTENSITY ALLOGENEIC TRANSPLANT PREPARATIVE REGIMENS FOR AML OR MDS.
Chicago-tyylinen lähdeviittausLuger, Selina M., et al. SIMILAR OUTCOMES USING MYELOABLATIVE VERSUS REDUCED INTENSITY ALLOGENEIC TRANSPLANT PREPARATIVE REGIMENS FOR AML OR MDS. 2011.
MLA-viiteLuger, Selina M., et al. SIMILAR OUTCOMES USING MYELOABLATIVE VERSUS REDUCED INTENSITY ALLOGENEIC TRANSPLANT PREPARATIVE REGIMENS FOR AML OR MDS. 2011.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.